TNFα Monoclonal Antibody for Acute Spinal Cord Injury

Clinical trial NCT04988425 · UNKNOWN

Trial details

NCT number: NCT04988425
Sponsor: Shanghai Changzheng Hospital
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Spinal Cord Injuries

Start date: 2022-09-01
Primary completion: 2023-08-30
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.